Cognitive Processing Therapy for Post-Traumatic Stress Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
Populations facing health disparities include groups with significantly higher rates of posttraumatic stress disorder than the general population who frequently experience lived experience stress, which may complicate posttraumatic stress disorder symptom presentations. However, there are currently no posttraumatic stress disorder treatments designed to meet the unique needs of these individuals.
The proposed study will pilot an adaptation of Cognitive Processing Therapy (a gold-standard treatment for posttraumatic stress disorder) that has been modified to incorporate the impact of lived experience stress as an additional treatment target. This project has the potential to advance our understanding of how to enhance Cognitive Processing Therapy in order to optimize posttraumatic stress disorder treatment response and mitigate health disparities.
Who Is on the Research Team?
Cara Herbitter, PhD, MPH
Principal Investigator
Psychiatry CABUSM and National Center for PTSD, VA Boston Healthcare System
Are You a Good Fit for This Trial?
This trial is for people diagnosed with post-traumatic stress disorder (PTSD), especially those from groups who face extra life stresses or health disparities. Participants should be adults able to take part in therapy sessions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Processing Therapy (CPT)
- Cognitive Processing Therapy - Lived Experience Adaptation (CPT-LEAP)
Trial Overview
The study compares standard Cognitive Processing Therapy (CPT) with a new version called CPT-LEAP, which adds support for dealing with ongoing life stress. Both are talk therapies aimed at helping PTSD symptoms.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomized to this arm will receive the adapted CPT-LEAP treatment delivered in weekly one-hour sessions, using the CPT variable length format in line with standard VA practice (9-15 sessions).
Participants randomized to this arm will receive standard CPT treatment delivered in weekly one-hour sessions, using the CPT variable length format in line with standard VA practice (9-15 sessions).
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.